INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
55 hedge funds and large institutions have $379M invested in Inozyme Pharma in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more capital invested
Capital invested by funds: $379M → $379M (+$398K)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
55
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$16.1M | |
| 2 | +$4.57M | |
| 3 | +$3.82M | |
| 4 |
CCM
CAAS Capital Management
New York
|
+$3.52M |
| 5 |
Millennium Management
New York
|
+$2.95M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$8.26M | |
| 3 | -$2.34M | |
| 4 |
CA
CHI Advisors
New York
|
-$1.35M |
| 5 |
D.E. Shaw & Co
New York
|
-$248K |